DUBLIN, Iuni 26, 2023– Lipoti “Tagata Peptide Drug Market – Global and Regional Analysis: Taulai atu i Peptide Types, Products and Regional Analysis – Analysis and Forecast, 2024-2040″.
I le maeʻa ai o le faʻalauiloaina muamua o le maketi o le vailaʻau peptide faʻasaina muamua, o le maketi o vailaʻau faʻasaina i le lalolagi o loʻo valoia e tupu mai le 2024 i le 2040. O le maketi o loʻo faʻamoemoe e oʻo atu i le $ 60M i le 2024 ma le $ 17.38B i le 2040, faʻatasi ai ma le CAGR o le 38.94% sili atu. le vaitaimi o fa'ata'ita'iga 2025-2040.
O le maketi o vailaʻau faʻasaina o le peptide faʻatapulaʻaina i le lalolagi e tatau ona oʻo i le tuputupu aʻe tele i le vaitau o faʻataʻitaʻiga mai le 2025 i le 2040, faʻamalosia i se vaega tele e ala i le folafolaga o se mea fou faʻatapulaʻaina peptide pipeline lea e le o toe faʻatapulaʻaina i le talitali.O le agaʻi i luma i tekinolosi faʻainisinia, alualu i luma i le faʻatauga o vailaʻau peptide synthetic i tausaga talu ai nei, ma tau taugofie na maua e nei biomolecules i faʻamaʻi eseese o nisi ia o mea faʻaopoopo e fesoasoani i le faʻatupulaia o le faʻatupulaia i le vaitau o faʻataʻitaʻiga.
O le suʻesuʻeina o aʻafiaga mo taimi pupuu ma taimi umi o loʻo faʻatinoina i luga o mea e matua aʻafia ai le maketi, e pei o avetaavale, faʻalavelave ma avanoa.Ole su'esu'ega pu'upu'u e fa'atatau ile piriota 2020-2025 ma le su'esu'ega umi ole vaitaimi ole 2026-2040.
O atinaʻe autu ma taʻiala na faʻaaogaina e nisi o taʻaloga autu i lenei maketi ua aofia ai i le iloiloga o aʻafiaga.E le gata i lea, o nei atinaʻe autu e iloiloina e malamalama ai i avanoa i le lumanaʻi mo le tuʻufaʻatasia o tekinolosi faʻapitoa e ausia ai taunuuga sili atu.E le gata i lea, o le faʻatagaina ma le faʻalauiloaina o kamupani ma ofisa pateni o loʻo amanaʻia foʻi pe a suʻesuʻeina le malosi o le maketi o le lalolagi mo vailaʻau peptide faʻasaina.
Tulaga Mana'omia ma Fa'agata O mea nei e mana'omia mo le maketi o le Peptide Dependence Inhibitors i le lalolagi atoa:
4 Va'aiga Aotelega o Maketi 4.1 Fa'atomuaga 4.1.1 Fa'atulagaina ma Fuafuaga o Peptides Fa'atapula'aina 4.1.2 Ituaiga o Peptides Fa'atapula'aina 4.2 Fa'afouina o Peptides Fa'atapula'aina 4.3 Fa'atupuina o Peptides Fa'atapula'aina e pei o Vailaau Fa'asaina 4.4 Va'aiga Fa'ata'ita'i 4.5 Fa'asologa o Alamanuia Fa'atauga 4. Itu'aiga Fa'atauga Fa'apitoa ) ) 4.7 Tulaga autu o alamanuia i luga o le ala o le folasaga 4.8 Tulaga autu o alamanuia - alualu i luma faatekinolosi 4.9 Tele maketi o loʻo i ai nei ma le faʻatupulaia o le gafatia, piliona USD, 2024-2040 ma le faʻafouina mo kamupani o loʻo gaosia fualaau faʻasaina peptide.
5 Meatotino o peptides fa'atapula'aina 5.1 Meatotino o peptides fa'atapula'a fa'atulafonoina 5.2 Fa'asologa o peptides fa'atapula'aina 5.2.1 Lisi vaila'au o peptides ma fa'afeso'ota'i 5.2.2 Lisi vaila'au o peptide i fa'alava (CLIPS) 5.2.3 Fa'asagaga o peptide. su'esu'ega (5.2.5 Liquid-Phase Peptide Synthesis (LPPS) 5.2.6 Solid-Phase Peptide Synthesis (SPPS) 5.3 Agai i luma i le Peptide Technology 5.3.1 Peptide Synthesis Fa'aaogaina Microfluidics 5.3.2 Solid-Phase Peptide Synthesis Fa'aaogaina o le Peptide Fa'aaliga 5.4. Filifili System
6 Fa'amaumauga o Alamanuia 6.1 Va'aiga Lautele 6.2 Fa'afitauli ma Auala Fa'atagaga Fa'atonu mo Peptides Fa'atapula'aina 6.3 Tulaga Fa'atonutonu mo Peptides Fa'atapula'aina 6.4 Fa'atonuga a le US ma Fa'atonuga 6.4.1 Fa'ataga Su'ega Falema'i 6.4.2 Fa'ataga Fa'atauga a le US 6.4.3 Fa'atonuga ole US FDA. tulafono 6.5 manaoga fa'aletulafono a Europa ma fa'avae 6.5.1 Fa'agasologa o talosaga laisene a le EMA 6.5.2 Tulaga fa'atotonugalemu 6.5.3 Tulaga fa'apitoa 6.5.4 Tulaga fa'ale-tagata 6.5.5 Ta'iala a le atunu'u 6.6 Mana'oga fa'aletulafono ma fa'avae i Asia ma le Pasefika 6.6.1 Manaoga faaletulafono ma fausaga i Iapani 6.7 Tulaga o le toe totogiina 6.7.1 Tulaga o le toe totogiina o faama'i autoimmune.
7 Fuafuaga o Maketi 7.1 Su'esu'ega o A'afiaga 7.2 Fa'atauga o Maketi 7.2.1 Fa'ateleina le Feso'ota'i ma Feso'ota'iga Feso'ota'i 7.2.2 Fa'atupuina o Faiga Fa'atino Fa'atapula'a 7.2.3 Tapula'a o Peptides masani 7.2.4 Fa'ateleina Fa'atupega a le Malo ma Tagata Tuma'oti 7.2.4.1 Fa'atupeina a Kamupani Tuma'oti. .4 .2 Fa'atupe a kamupani fa'amauina 7.2.4.3 Fa'atupe e fa'alapotopotoga a le malo 7.3 Fa'agata tau maketi 7.3.1 Fa'ateleina le tauvaga mo meaola fa'aola 7.3.2 Tulaga lamatia o a'afiaga fa'ama'i ma mea fa'aletonu ole ADME 7.4 Avanoa tau maketi 7.4.1 Fa'atapula'a peptide ile su'eina o vaila'au 7.4.2 Fa'aaogāga 'ese'ese faiga neura ma togafitiga o le kanesa
8 Fa'atauva'a fanua 8.1 Va'aiga lautele o le fa'atauva'a 8.1.1 Atina'e 'autū 8.1.2 Fa'atonuga fa'aletulafono 8.1.3 Tu'ufa'atasiga ma fa'atauga 8.1.4 Gaoioiga fa'atasi 8.1.5 Gaoioiga tau tupe 8.1.6 Atina'e tau falema'i
9 Maketi i le lalolagi atoa o le taofiofia o vaila'au peptide (i fa'atonuga), miliona USD, 2024–2040 9.1 Fa'ata'ita'iga Fa'ata'ita'i Fa'ata'ita'i mo Togafitiga Fa'asa'o Peptide 9.1.1 Togafitiga o le Vaega II II) 9.1.2.3 Fa'amatalaga Lelei, Saogalemu, ma Fa'apalepale (Vaega 1) 9.1 .2.4 Su'esu'ega Fa'apitoa o le BT5528 9.1.3 PN-9439.1.3.1 Fa'atomuaga o Oloa 9.1.3.2 Su'esu'ega Fa'ata'ita'iga (Vaega 2) 9.1.3.3 Fa'amatalaga lelei, saogalemu ma le fa'amalieina (Vaega II) 9.1.4 PN-24.1 Fa'atomuaga i1.1. 4.2 Fuafuaga su'esu'e (Vaega IIb) 9.1.4.3 Fa'amaumauga o le aoga, saogalemu ma le gafatia (Vaega IIb) 9.1.5 Rusfertide (PTG-300) 9.1.5.1 Va'aiga lautele o oloa 9.1.5.2 Fuafuaga su'esu'e (Vaega II) 9.1.5.3 Lelei, saogalemu fa'amatalaga fa'apalepale (Vaega IIa) 9.1.6 Laasaga III vaila'au e mafai 9.1.7 Zilukoplan (RA101495) 9.1.7.1 Va'aiga lautele o oloa 9.1.7.2 Fuafuaga su'esu'e (Vaega III) 9.1.7.3 Fa'amaumauga o le aoga, saogalemu ma le gafatia (Vaega III.7) 49.1. Pharmacokinetic and pharmacodynamic profile of Zilucoplan (Vaega I) 9.1.8 Rusfertide (PTG- 300) 9.1.8.1 Va'aiga lautele o oloa 9.1.8.2 Fuafuaga su'esu'e (Vaega III) 9.1.8.3 Fa'amatalaga aoga, saogalemu ma le gafatia (Vaega II) 9.2 atinae dynamics o le maketi o le lalolagi mo fualaau faasaina peptide faatapulaaina, USD miliona, 2024-2040 manuia 9.2.2.2 Tau o le gaosiga API (CDMO)
10 maketi i le lalolagi atoa mo vailaʻau faʻatapulaʻa gaioiga peptide (i ituaiga peptide), US $ miliona, 2024-2040 fesoʻotaʻi peptide (DRP))
11 Maketi i le lalolagi atoa mo fualaau faasaina peptide faatapulaaina (e oloa gafatia), miliona USD, 2024–2040 (RA101495) 11.1.2.1 gaosiga API (aiga) 11.1.2.2 API manaoga mo le 2024-2040 11.1.3 Rusfertide (PTG-301) .3.1 API Gaosiga (Ofo) Tau 11.1.4 PN-94311.1.4.1 API Gaosiga (Ofo) 11.1.4.2 API Demand Forecast 2024-2040
Taimi meli: Iul-06-2023